Our solutions enable you to minimize risks in drug development, streamline productivity and lower cost across key aspects of pre-clinical and clinical development, Portfolio Strategy, and Business Development.
Mispriced risk: Finding undervalued biopharma business development opportunities
AI can deliver better healthcare and longevity for all. Here's how.
Empowering life sciences teams to make better decisions
Intelligencia Demo at CB Insights Future of Health 2021
Vangelis Vergetis presenting at the 2021 CNS Summit
Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accel erate Scientific Breakthroughs
America’s most promising AI companies of 2021
Assessing drug development risk using Big Data and Machine Learning
A Machine Learning approach for assessing drug development risk
Harnessing the Power of AI in Greece: Embarking on the Path to Value
Intelligencia.ai: Machine learning: A Catalyst for Drug Development
Take the risk out of clinical drug development
Optimizing Real World Data for Therapeutic Development: The Role of Artificial Intelligence
Dimitrios Skaltsas: AI at the heart of drug-development company